Copalia was also studied in an active-controlled study of 130 hypertensive patients with diastolic blood pressure ≥ 110 mmHg and < 120 mmHg.
Copalia’ t uuriti ka aktiivse võrdlusravimiga kontrollitud uuringus, kus osales 130 hüpertensiivset patsienti diastoolse vererõhuga ≥110 ja < 120 mmHg.